ABCD Autumn Meeting, London, 2010a - Abstract
16.6% (1 in 6) patients who continued insulin at the time of exenatide start came off insulin in the Association of British Clinical Diabetologists (ABCD) Nationwide Exenatide Audit
K.Y. Thong1, B. Jose1, N. Sukumar1, M.L. Cull1, A.P. Mills1, T. Sathyapalan2, W. Shafiq2, A. Rigby2, C. Walton2, R.E.J. Ryder1, on behalf of the ABCD nationwide exenatide audit contributors;
1Diabetes, City Hospital, Birmingham, United Kingdom
2Diabetes, Hull Royal Infirmary, Hull, United Kingdom.
